In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Intricacies of Precision Medicine for Biotechs
Andrew Garrett discusses challenges such as patient recruitment for biotechs developing therapies for targeted populations with rare diseases.
-
Navigating an Ever Evolving Regulatory and Pharmacovigilance Landscape
In the 2020 edition of SCRIP Asia 100 ICON's Chuhua Wu outlines the variations in the structures, processes and outcomes of the pharmacovigilance status among Asian countries, with many diversities and complexities, and how a trend toward a more stringent regulatory environment in Asia is predicted.
-
The Danger of 'Going too far' with AI
Andrew Garrett spoke on a panel at the Financial Times Pharmaceutical & Biotechnology conference, about the recent integration of artificial intelligence (AI) enabled services in pharma R&D.
-
Risk-Based Monitoring and Real-World Data: A Decentralised Ecosystem
Ian O'Shaughnessy considers how to ensure a reality for the bright future of digitisation as clinical trials evolve.
-
Trends in Payer Reliance on ICER Assessments
A thought leadership authored by Jenny Lee and Eric Latch, based on the ICON’s whitepaper regarding payer reliance on ICER assessments and perceptions on value-based pricing.
-
A Strategic Business Plan to ensure success under MDR/IVDR
David Novotny and Angela Brown share their insights in this Medical Design and Outsourcing article as to how manufacturers can develop a strategic business model that will prepare them for success under the new MDR/IVDR reforms
-
-
Trends in Biosimilar Market Access
A thought leadership article authored by Jenny Lee and Gene Chieh, investigating how biosimilars have gained momentum in a growing number of markets.
-
Biomarker-driven Landscape in Clinical Trials
ICON's Nicole Cowan is interviewed in the latest edition of Clinical OMICs about the new biomarker-driven landscape in clinical trials and the nuances of drug-diagnostics co-development programs.
-
Social Media Outreach
ICON expert Gretchen Goller considers social media outreach's beneficial effect on patient connectivity to date in the October 2019 edition of Pharma Voice.
